Predictive Oncology Inc.
POAI
$5.89
$0.346.13%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 728.20K | 728.50K | 793.10K | 687.70K | 395.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 728.20K | 728.50K | 793.10K | 687.70K | 395.70K |
| Cost of Revenue | 362.30K | 365.10K | 360.80K | 338.10K | 289.30K |
| Gross Profit | 366.00K | 363.40K | 432.30K | 349.50K | 106.30K |
| SG&A Expenses | 10.72M | 9.59M | 9.47M | 10.68M | 11.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.08M | 9.96M | 9.83M | 11.02M | 11.63M |
| Operating Income | -10.35M | -9.23M | -9.04M | -10.33M | -11.23M |
| Income Before Tax | -84.01M | -8.50M | -8.97M | -10.25M | -11.14M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -84.01 | -8.50 | -8.97 | -10.25 | -11.14 |
| Earnings from Discontinued Operations | -322.90K | -1.28M | -1.92M | -2.41M | -2.83M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -84.33M | -9.78M | -10.89M | -12.66M | -13.97M |
| EBIT | -10.35M | -9.23M | -9.04M | -10.33M | -11.23M |
| EBITDA | -10.21M | -9.09M | -8.90M | -10.19M | -11.09M |
| EPS Basic | -120.66 | -20.66 | -27.49 | -37.94 | -45.89 |
| Normalized Basic EPS | -75.01 | -11.10 | -14.00 | -19.23 | -23.33 |
| EPS Diluted | -120.71 | -20.71 | -27.54 | -38.03 | -45.99 |
| Normalized Diluted EPS | -75.01 | -11.10 | -14.00 | -19.23 | -23.33 |
| Average Basic Shares Outstanding | 2.25M | 1.96M | 1.66M | 1.45M | 1.28M |
| Average Diluted Shares Outstanding | 2.25M | 1.96M | 1.66M | 1.45M | 1.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |